Pharmacology Biochemistry and Behavior 1994-02-01

Relationships between arousal and cognition-enhancing effects of oxiracetam.

A Cavoy, B Van Golf-Racht, J Delacour

Index: Pharmacol. Biochem. Behav. 47(2) , 283-7, (1994)

Full Text: HTML

Abstract

Cognition-enhancing effects of no-otropic drugs are currently ascribed to an increase in arousal level. In order to test this hypothesis, we studied the effects of three doses of oxiracetam (25, 50 and 100 mg/kg IP) on a radial maze task and on slow wave sleep (SWS) latency in a familiar environment. The 25- and 100-mg/kg doses, but not the 50-mg/kg, significantly improved performance in the memory task. On the other hand, SWS latency was significantly increased by 50 and 100 mg/kg, with the effect of the 25-mg/kg dose going in the same direction but only approaching significance. These results give only a partial support to the "arousal factor hypothesis." Other factors are probably involved in the promnesic effects of oxiracetam.


Related Compounds

Related Articles:

Minaprine, but not oxiracetam, prevents desipramine-induced impairment of avoidance learning in mice.

1995-01-01

[Pol. J. Pharmacol. 47(1) , 69-73, (1995)]

Pre- and postprandial pyridostigmine and oxiracetam effects on growth hormone secretion in anorexia nervosa.

1996-10-01

[Psychoneuroendocrinology 21(7) , 621-9, (1996)]

Putative cognition enhancers reverse kynurenic acid antagonism at hippocampal NMDA receptors.

1995-01-16

[Eur. J. Pharmacol. 272(2-3) , 203-9, (1995)]

Enhancement of contextual fear-conditioning by putative (+/-)-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor modulators and N-methyl-D-aspartate (NMDA) receptor antagonists in DBA/2J mice.

1997-09-12

[Brain Res. 768(1-2) , 197-207, (1997)]

Effect of alaptide, its analogues and oxiracetam on memory for an elevated plus-maze in mice.

1996-10-24

[Eur. J. Pharmacol. 314(1-2) , 1-7, (1996)]

More Articles...